Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Robinson, David F.
2002.
Vol. 3,
Issue. ,
p.
195.
Marchetti, Monia
2004.
Drug-eluting stents: from evidence to policy.
Expert Review of Medical Devices,
Vol. 1,
Issue. 1,
p.
49.
Trowbridge, Robert L
Araoz, Philip A
Gotway, Michael B
Bailey, Richard A
and
Auerbach, Andrew D
2004.
The effect of helical computed tomography on diagnostic and treatment strategies in patients with suspected pulmonary embolism.
The American Journal of Medicine,
Vol. 116,
Issue. 2,
p.
84.
Linden, Luan
Vondeling, Hindrik
Packer, Claire
and
Cook, Alison
2007.
Does the National Institute for Health and Clinical Excellence only appraise new pharmaceuticals?.
International Journal of Technology Assessment in Health Care,
Vol. 23,
Issue. 3,
p.
349.
Chauhan, D.
and
Mason, A.
2008.
Factors affecting the uptake of new medicines in secondary care a literature review.
Journal of Clinical Pharmacy and Therapeutics,
Vol. 33,
Issue. 4,
p.
339.
Rogowski, Wolf H
Hartz, Susanne C
and
John, Jürgen H
2008.
Clearing up the hazy road from bench to bedside: A framework for integrating the fourth hurdle into translational medicine.
BMC Health Services Research,
Vol. 8,
Issue. 1,
Wild, Claudia
Simpson, Sue
Douw, Karla
Geiger-Gritsch, Sabine
Mathis, Stefan
and
Langer, Thomas
2009.
Information service on new and emerging health technologies: Identification and prioritization processes for a European Union–wide newsletter.
International Journal of Technology Assessment in Health Care,
Vol. 25,
Issue. S2,
p.
48.
Farahani, Mansour
Subramanian, S.V.
and
Canning, David
2009.
The effect of changes in health sector resources on infant mortality in the short-run and the long-run: A longitudinal econometric analysis.
Social Science & Medicine,
Vol. 68,
Issue. 11,
p.
1918.
Duarte, Paulo Schiavom
Ramos, Daniel Garkauskas
and
Pereira, Júlio Cesar Rodrigues
2011.
Padrão de incorporação de fármacos antiretrovirais pelo sistema público de saúde no Brasil.
Revista Brasileira de Epidemiologia,
Vol. 14,
Issue. 4,
p.
541.
Lal, Jonathan A
Schulte in den Bäumen, Tobias
Morré, Servaas A
and
Brand, Angela
2011.
Public health and valorization of genome-based technologies: a new model.
Journal of Translational Medicine,
Vol. 9,
Issue. 1,
Cardwell, Chris R.
Hicks, Blanaid M.
Hughes, Carmel
and
Murray, Liam J.
2014.
Statin Use After Colorectal Cancer Diagnosis and Survival: A Population-Based Cohort Study.
Journal of Clinical Oncology,
Vol. 32,
Issue. 28,
p.
3177.
Lima‐Dellamora, Elisangela da Costa
Caetano, Rosângela
Gustafsson, Lars L.
Godman, Brian B.
Patterson, Ken
and
Osorio‐de‐Castro, Claudia Garcia Serpa
2014.
An Analytical Framework for Assessing Drug and Therapeutics Committee Structure and Work Processes in Tertiary Brazilian Hospitals.
Basic & Clinical Pharmacology & Toxicology,
Vol. 115,
Issue. 3,
p.
268.
Westerling, Ragnar
Westin, Marcus
McKee, Martin
Hoffmann, Rasmus
Plug, Iris
Rey, Grégoire
Jougla, Eric
Lang, Katrin
Pärna, Kersti
Alfonso, José L.
and
Mackenbach, Johan P.
2014.
The timing of introduction of pharmaceutical innovations in seven European countries.
Journal of Evaluation in Clinical Practice,
Vol. 20,
Issue. 4,
p.
301.
Reyes-Santias, Francisco
and
Antelo, Manel
2021.
Explaining the adoption and use of computed tomography and magnetic resonance image technologies in public hospitals.
BMC Health Services Research,
Vol. 21,
Issue. 1,
Reyes-Santias, Francisco
Cordova-Arevalo, Octavio
Dominguez, Ivan Busto
and
Antelo, Manel
2023.
Factors influencing medical imaging technology uptake by private hospitals.
Health and Technology,
Vol. 13,
Issue. 6,
p.
937.